Literature DB >> 22290037

Cognitive-behavioral therapy for subthreshold bulimia nervosa: A case series.

C B Peterson1, K B Miller, M G Willer, J Ziesmer, N Durkin, A Arikian, S J Crow.   

Abstract

The extent to which cognitive-behavioral therapy (CBT) is helpful in treating individuals with bulimic symptoms who do not meet full criteria for bulimia nervosa is unclear. The purpose of this investigation was to examine the potential efficacy of CBT for eating disorder individuals with bulimic symptoms who do not meet full criteria for bulimia nervosa. Twelve participants with subthreshold bulimia nervosa were treated in a case series with 20 sessions of CBT. Ten of the 12 participants (83.3%) completed treatment. Intent-to-treat abstinent percentages were 75.0% for objectively large episodes of binge eating (OBEs), 33.3% for subjectively large episodes of binge eating (SBEs), and 50% for purging at end of treatment. At one year follow-up, 66.7% were abstinent for OBEs, 41.7% for SBEs, and 50.0% for purging. The majority also reported improvements in associated symptoms. This case series provides support for the use of CBT with individuals with subthreshold bulimia nervosa.

Entities:  

Mesh:

Year:  2011        PMID: 22290037     DOI: 10.1007/BF03325133

Source DB:  PubMed          Journal:  Eat Weight Disord        ISSN: 1124-4909            Impact factor:   4.652


  17 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

2.  DSM-IV threshold versus subthreshold bulimia nervosa.

Authors:  Daniel le Grange; Roslyn B Binford; Carol B Peterson; Scott J Crow; Ross D Crosby; Marjorie H Klein; Anna M Bardone-Cone; Thomas E Joiner; James E Mitchell; Stephen A Wonderlich
Journal:  Int J Eat Disord       Date:  2006-09       Impact factor: 4.861

Review 3.  Psychological treatment of eating disorders.

Authors:  G Terence Wilson
Journal:  Annu Rev Clin Psychol       Date:  2005       Impact factor: 18.561

Review 4.  The outcome of bulimia nervosa: findings from one-quarter century of research.

Authors:  Hans-Christoph Steinhausen; Sandy Weber
Journal:  Am J Psychiatry       Date:  2009-11-02       Impact factor: 18.112

5.  A multicenter comparison of cognitive-behavioral therapy and interpersonal psychotherapy for bulimia nervosa.

Authors:  W S Agras; T Walsh; C G Fairburn; G T Wilson; H C Kraemer
Journal:  Arch Gen Psychiatry       Date:  2000-05

6.  Are diagnostic criteria for eating disorders markers of medical severity?

Authors:  Rebecka Peebles; Kristina K Hardy; Jenny L Wilson; James D Lock
Journal:  Pediatrics       Date:  2010-04-12       Impact factor: 7.124

7.  Test-retest reliability of the eating disorder examination.

Authors:  S L Rizvi; C B Peterson; S J Crow; W S Agras
Journal:  Int J Eat Disord       Date:  2000-11       Impact factor: 4.861

8.  Increased mortality in bulimia nervosa and other eating disorders.

Authors:  Scott J Crow; Carol B Peterson; Sonja A Swanson; Nancy C Raymond; Sheila Specker; Elke D Eckert; James E Mitchell
Journal:  Am J Psychiatry       Date:  2009-10-15       Impact factor: 18.112

9.  A randomized trial comparing the efficacy of cognitive-behavioral therapy for bulimia nervosa delivered via telemedicine versus face-to-face.

Authors:  James E Mitchell; Ross D Crosby; Stephen A Wonderlich; Scott Crow; Kathy Lancaster; Heather Simonich; Lorraine Swan-Kremeier; Christianne Lysne; Tricia Cook Myers
Journal:  Behav Res Ther       Date:  2008-03-10

10.  Full syndromal versus subthreshold anorexia nervosa, bulimia nervosa, and binge eating disorder: a multicenter study.

Authors:  Scott J Crow; W Stewart Agras; Katherine Halmi; James E Mitchell; Helena C Kraemer
Journal:  Int J Eat Disord       Date:  2002-11       Impact factor: 4.861

View more
  1 in total

Review 1.  Treatment Protocols for Eating Disorders: Clinicians' Attitudes, Concerns, Adherence and Difficulties Delivering Evidence-Based Psychological Interventions.

Authors:  Glenn Waller
Journal:  Curr Psychiatry Rep       Date:  2016-04       Impact factor: 5.285

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.